The Cost of Ankylosing Spondylitis in the UK Using Linked Routine and Patient-Reported Survey Data
Open Access
- 17 July 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (7) , e0126105
Abstract
Ankylosing spondylitis (AS) is a chronic inflammatory arthritis which typically begins in early adulthood and impacts on healthcare resource utilisation and the ability to work. Previous studies examining the cost of AS have relied on patient-reported questionnaires based on recall. This study uses a combination of patient-reported and linked-routine data to examine the cost of AS in Wales, UK. Participants in an existing AS cohort study (n = 570) completed questionnaires regarding work status, out-of-pocket expenses, visits to health professionals and disease severity. Participants gave consent for their data to be linked to routine primary and secondary care clinical datasets. Health resource costs were calculated using a bottom-up micro-costing approach. Human capital costs methods were used to estimate work productivity loss costs, particularly relating to work and early retirement. Regression analyses were used to account for age, gender, disease activity. The total cost of AS in the UK is estimated at £19016 per patient per year, calculated to include GP attendance, administration costs and hospital costs derived from routine data records, plus patient-reported non-NHS costs, out-of-pocket AS-related expenses, early retirement, absenteeism, presenteeism and unpaid assistance costs. The majority of the cost (>80%) was as a result of work-related costs. The major cost of AS is as a result of loss of working hours, early retirement and unpaid carer’s time. Therefore, much of AS costs are hidden and not easy to quantify. Functional impairment is the main factor associated with increased cost of AS. Interventions which keep people in work to retirement age and reduce functional impairment would have the greatest impact on reducing costs of AS. The combination of patient-reported and linked routine data significantly enhanced the health economic analysis and this methodology that can be applied to other chronic conditions.Keywords
This publication has 35 references indexed in Scilit:
- HERALD (Health Economics using Routine Anonymised Linked Data)BMC Medical Informatics and Decision Making, 2012
- Services for people with ankylosing spondylitis in the UK—a survey of rheumatologists and patientsRheumatology, 2011
- Protocol for a population-based Ankylosing Spondylitis (PAS) cohort in WalesBMC Musculoskeletal Disorders, 2010
- The SAIL Databank: building a national architecture for e-health research and evaluationBMC Health Services Research, 2009
- Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force ReportValue in Health, 2009
- The SAIL databank: linking multiple health and social care datasetsBMC Medical Informatics and Decision Making, 2009
- Health care utilization in patients with spondyloarthropathiesRheumatology, 2008
- Costs and quality of life of patients with ankylosing spondylitis in Hong KongRheumatology, 2008
- Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Estimating the cost of illness.American Journal of Public Health and the Nations Health, 1967